{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:43:53Z","timestamp":1761561833323,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.carrev.2013.07.005","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T21:01:46Z","timestamp":1376946106000},"page":"284-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Two-year follow-up of percutaneous coronary intervention using EucaTax or Cypher"],"prefix":"10.1016","volume":"14","author":[{"given":"Yulia A.","family":"Shuvalova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman O.","family":"Shirokov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violetta I.","family":"Kaminnaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatoliy N.","family":"Samko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander I.","family":"Kaminnyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2013.07.005_bb0005","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2013.07.005_bb0010","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2013.07.005_bb0015","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/eurheartj\/ehn021","article-title":"Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients","volume":"29","author":"Billinger","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2013.07.005_bb0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jama.294.7.819","article-title":"Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials","volume":"294","author":"Kastrati","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2013.07.005_bb0025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1001\/jama.295.8.895","article-title":"for the REALITY Trial Investigators. Sirolimus vs. paclitaxel eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial","volume":"295","author":"Morice","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2013.07.005_bb0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.299.4.409","article-title":"for the SORT OUT II Investigators. Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial","volume":"299","author":"Gall\u00f8e","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2013.07.005_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cpcardiol.2005.09.002","article-title":"Drug-eluting coronary stents","volume":"31","author":"Salam","year":"2006","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.carrev.2013.07.005_bb0040","first-page":"537","article-title":"Biodegradable stents and non-biodegradable stents","volume":"57","author":"Garg","year":"2009","journal-title":"Minerva Cardioangiol"},{"key":"10.1016\/j.carrev.2013.07.005_bb0045","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4244\/EIJV7I8A155","article-title":"Safety and efficacy of biodegradable vs. durable polymer drug-eluting: evidence from a meta-analysis of randomised trials","volume":"7","author":"Navarese","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2013.07.005_bb0050","first-page":"335","article-title":"Efficacy and safety of a double-coated paclitaxel-eluting stent: the EUCATAX trial","volume":"77","author":"Rodriguez","year":"2011","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2013.07.005_bb0055","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2013.07.005_bb0060","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1148\/89.6.1040","article-title":"Mechanics of selective coronary artery catheterization via femoral approach","volume":"89","author":"Amplatz","year":"1967","journal-title":"Radiology"},{"key":"10.1016\/j.carrev.2013.07.005_bb0065","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/89.5.815","article-title":"Selective coronary arteriography: part I: a percutaneous transfemoral technic","volume":"89","author":"Judkins","year":"1967","journal-title":"Radiology"},{"key":"10.1016\/j.carrev.2013.07.005_bb0070","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2007.06.015","article-title":"Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial","volume":"50","author":"Togni","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2013.07.005_bb0075","first-page":"330","article-title":"Two-year clinical follow-up of the unrestricted use of the paclitaxel-eluting stent compared to the sirolimus-eluting stent as part of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry","volume":"2","author":"Daemen","year":"2006","journal-title":"EuroIntervention"},{"key":"10.1016\/j.carrev.2013.07.005_bb0080","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/eurheartj\/ehp224","article-title":"Twenty-four months clinical outcomes of sirolimus-eluting stents for the treatment of small coronary arteries: the long-term SES-SMART clinical study","volume":"30","author":"Menozzi","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2013.07.005_bb0085","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","article-title":"Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patient with complex coronary artery disease: a randomized controlled trial","volume":"294","author":"Stone","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2013.07.005_bb0090","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/eurheartj\/ehi721","article-title":"Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels","volume":"27","author":"Mehilli","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2013.07.005_bb0095","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1161\/CIRCULATIONAHA.105.601823","article-title":"Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents","volume":"113","author":"Kastrati","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2013.07.005_bb0100","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1161\/CIRCULATIONAHA.106.666396","article-title":"Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease","volume":"114","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2013.07.005_bb0105","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(08)61244-1","article-title":"Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial","volume":"372","author":"Windecker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2013.07.005_bb0110","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1093\/eurheartj\/ehp352","volume":"30","author":"Byrne","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2013.07.005_bb0115","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIRCINTERVENTIONS.108.823443","article-title":"NOBORI 1 Clinical Investigators. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Libert\u00e9 paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial\u2014phase 2","volume":"2","author":"Chevalier","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2013.07.005_bb0120","unstructured":"NEXT: biolimus-eluting stent non-inferior to Xience\/Promus. Available at: http:\/\/www.theheart.org\/article\/1516365.do\/. Accessed Mar 10, 2013."},{"key":"10.1016\/j.carrev.2013.07.005_bb0125","unstructured":"BIOFLOW II: new bioabsorbable-polymer\/thin-strut sirolimus stent shows promise. Available at: http:\/\/www.theheart.org\/article\/1541807.do\/. Accessed May 21, 2013."}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838913001139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838913001139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:09:02Z","timestamp":1761559742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838913001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S1553838913001139"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2013.07.005","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-year follow-up of percutaneous coronary intervention using EucaTax or Cypher","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2013.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}